Find Research Outputs

Search concepts
Selected Filters
2017
8 Citations

Baseline characteristics of patients enrolled in the Exenatide Study of Cardiovascular Event Lowering (EXSCEL)

Mentz, R. J., Bethel, M. A., Gustavson, S., Thompson, V. P., Pagidipati, N. J., Buse, J. B., Chan, J. C., Iqbal, N., Maggioni, A. P., Marso, S. P., Ohman, P., Poulter, N., Ramachandran, A., Zinman, B., Hernandez, A. F. & Holman, R. R. May 1 2017 In : American Heart Journal. 187, p. 1-9 9 p.

Research output: Contribution to journalArticle

Placebos
Dipeptidyl-Peptidase IV Inhibitors
Cerebrovascular Disorders
Latin America
Peripheral Arterial Disease

Differential Use of Screening Mammography in Older Women Initiating Metformin versus Sulfonylurea

Hong, J. L., Henderson, L. M., Jonsson Funk, M., Lund, J. L., Buse, J. B., Pate, V. & Stürmer, T. Jun 1 2017 In : Pharmacoepidemiology and Drug Safety. 26, 6, p. 666-675 10 p.

Research output: Contribution to journalArticle

Metformin
Mammography
Breast Neoplasms
Incidence
Medicare
22 Citations

Hypoxia and H2O2 Dual-Sensitive Vesicles for Enhanced Glucose-Responsive Insulin Delivery

Yu, J., Qian, C., Zhang, Y., Cui, Z., Zhu, Y., Shen, Q., Ligler, F. S., Buse, J. B. & Gu, Z. Feb 8 2017 In : Nano Letters. 17, 2, p. 733-739 7 p.

Research output: Contribution to journalArticle

insulin
Insulin
hypoxia
glucose
Glucose
12 Citations

Pancreatic safety of sitagliptin in the TECOS study

for the TECOS Study Group Feb 1 2017 In : Diabetes care. 40, 2, p. 164-170 7 p.

Research output: Contribution to journalArticle

Pancreatitis
Pancreatic Neoplasms
Safety
Dipeptidyl-Peptidase IV Inhibitors
Placebos
9 Citations

Red Blood Cells for Glucose-Responsive Insulin Delivery

Wang, C., Ye, Y., Sun, W., Yu, J., Wang, J., Lawrence, D. S., Buse, J. B. & Gu, Z. May 10 2017 In : Advanced Materials. 29, 18, 1606617

Research output: Contribution to journalArticle

Insulin
Glucose
Blood
Cells
Cell membranes
8 Citations

Sitagliptin and risk of fractures in type 2 diabetes: Results from the TECOS trial

on behalf of the TECOS Study Group Jan 1 2017 In : Diabetes, Obesity and Metabolism. 19, 1, p. 78-86 9 p.

Research output: Contribution to journalArticle

Type 2 Diabetes Mellitus
Osteoporotic Fractures
Metformin
Confidence Intervals
Odds Ratio

Update and next steps for real-world translation of interventions for type 2 diabetes prevention: Reflections from a diabetes care editors' expert forum. Diabetes care 2016;39:1186-1201

Cefalu, W. T., Buse, J. B., Tuomilehto, J., Fleming, G. A., Ferrannini, E., Gerstein, H. C., Bennett, P. H., Ramachandran, A., Raz, I., Rosenstock, J. & Kahn, S. E. Feb 1 2017 In : Diabetes care. 40, 2, p. e23-e24

Research output: Contribution to journalComment/debate

2016
13 Citations

Benefits of combination of insulin degludec and liraglutide are independent of baseline glycated haemoglobin level and duration of type 2 diabetes

Rodbard, H. W., Buse, J. B., Woo, V., Vilsbøll, T., Langbakke, I. H., Kvist, K. & Gough, S. C. L. Jan 1 2016 In : Diabetes, Obesity and Metabolism. 18, 1, p. 40-48 9 p.

Research output: Contribution to journalArticle

Glycosylated Hemoglobin A
Type 2 Diabetes Mellitus
Insulin
Hypoglycemia
Hypoglycemic Agents
20 Citations

Chronic exposure to arsenic and markers of cardiometabolic risk: A cross-sectional study in Chihuahua, Mexico

Mendez, M. A., González-Horta, C., Sánchez-Ramírez, B., Ballinas-Casarrubias, L., Cerón, R. H., Morales, D. V., Baeza Terrazas, F. A., Ishida, M. C., Gutiérrez-Torres, D. S., Saunders, R. J., Drobná, Z., Fry, R. C., Buse, J. B., Loomis, D., García-Vargas, G. G., Del Razo, L. M. & Stýblo, M. Jan 1 2016 In : Environmental Health Perspectives. 124, 1, p. 104-111 8 p.

Research output: Contribution to journalArticle

Arsenic
Mexico
Cross-Sectional Studies
Drinking Water
HDL Cholesterol
13 Citations

Design of DEVOTE (Trial Comparing Cardiovascular Safety of Insulin Degludec vs Insulin Glargine in Patients With Type 2 Diabetes at High Risk of Cardiovascular Events) – DEVOTE 1

Marso, S. P., McGuire, D. K., Zinman, B., Poulter, N. R., Emerson, S. S., Pieber, T. R., Pratley, R. E., Haahr, P. M., Lange, M., Frandsen, K. B., Rabøl, R. & Buse, J. B. Sep 1 2016 In : American Heart Journal. 179, p. 175-183 9 p.

Research output: Contribution to journalArticle

Type 2 Diabetes Mellitus
Safety
Random Allocation
Chronic Renal Insufficiency
Cardiovascular Diseases
1 Citations

Effect of glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors on colorectal cancer incidence and its precursors

Htoo, P. T., Buse, J. B., Gokhale, M., Marquis, M. A., Pate, V. & Stürmer, T. Aug 1 2016 In : European Journal of Clinical Pharmacology. 72, 8, p. 1013-1023 11 p.

Research output: Contribution to journalArticle

Dipeptidyl-Peptidase IV Inhibitors
Colorectal Neoplasms
Long-Acting Insulin
Incidence
Confidence Intervals
54 Citations

Effect of insulin glargine up-titration vs insulin degludec/liraglutide on glycated hemoglobin levels in patients with uncontrolled type 2 diabetes: The DUAL v randomized clinical trial

Lingvay, I., Manghi, F. P., García-Hernández, P., Norwood, P., Lehmann, L., Tarp-Johansen, M. J. & Buse, J. B. Mar 1 2016 In : JAMA - Journal of the American Medical Association. 315, 9, p. 898-907 10 p.

Research output: Contribution to journalArticle

Glycosylated Hemoglobin A
Type 2 Diabetes Mellitus
Randomized Controlled Trials
Insulin
Metformin
28 Citations

Effect of naltrexone-bupropion on major adverse cardiovascular events in overweight and obese patients with cardiovascular risk factors: A randomized clinical trial

Nissen, S. E., Wolski, K. E., Prcela, L., Wadden, T., Buse, J. B., Bakris, G., Perez, A. & Smith, S. R. Mar 8 2016 In : JAMA - Journal of the American Medical Association. 315, 10, p. 990-1004 15 p.

Research output: Contribution to journalArticle

Bupropion
Naltrexone
Randomized Controlled Trials
Placebos
Obesity
12 Citations

Efficacy and safety of liraglutide added to capped insulin treatment in subjects with type 1 diabetes: The adjunct two randomized trial

Ahren, B., Hirsch, I. B., Pieber, T. R., Mathieu, C., Gomez-Peralta, F., Hansen, T. K., Philotheou, A., Birch, S., Christiansen, E., Jensen, T. J. & Buse, J. B. Oct 1 2016 In : Diabetes Care. 39, 10, p. 1693-1701 9 p.

Research output: Contribution to journalArticle

Type 1 Diabetes Mellitus
Insulin
Safety
Placebos
Therapeutics
7 Citations

Genetic predictors of cardiovascular mortality during intensive glycemic control in type 2 diabetes: Findings from the ACCORD clinical trial

Shah, H. S., Gao, H., Morieri, M. L., Skupien, J., Marvel, S., Paré, G., Mannino, G. C., Buranasupkajorn, P., Mendonca, C., Hastings, T., Marcovina, S. M., Sigal, R. J., Gerstein, H. C., Wagner, M. J., Motsinger-Reif, A. A., Buse, J. B., Kraft, P., Mychaleckyj, J. C. & Doria, A. Nov 1 2016 In : Diabetes care. 39, 11, p. 1915-1924 10 p.

Research output: Contribution to journalArticle

Type 2 Diabetes Mellitus
Clinical Trials
Mortality
Genome
Diabetes Complications
8 Citations

IDegLira Improves Both Fasting and Postprandial Glucose Control as Demonstrated Using Continuous Glucose Monitoring and a Standardized Meal Test

Holst, J. J., Buse, J. B., Rodbard, H. W., Linjawi, S., Woo, V. C., Boesgaard, T. W., Kvist, K. & Gough, S. C. Mar 1 2016 In : Journal of Diabetes Science and Technology. 10, 2, p. 389-397 9 p.

Research output: Contribution to journalArticle

Insulin
Glucose
Meals
Fasting
Monitoring
1 Citations

Incorporating concomitant medications into genome-wide analyses for the study of complex disease and drug response

The ACCORD/ACCORDion Investigators Aug 17 2016 In : Frontiers in Genetics. 7, AUG, 138

Research output: Contribution to journalArticle

Hydroxymethylglutaryl-CoA Reductase Inhibitors
Genome-Wide Association Study
Genome
Pharmaceutical Preparations
Linear Models
2 Citations

LEADER 7: Cardiovascular risk profiles of US and European participants in the LEADER diabetes trial differ

Rutten, G. E. H. M., Tack, C. J., Pieber, T. R., Comlekci, A., Ørsted, D. D., Baeres, F. M. M., Marso, S. P. & Buse, J. B. Jun 2 2016 In : Diabetology and Metabolic Syndrome. 8, 1, 37

Research output: Contribution to journalArticle

Cardiovascular Diseases
Blood Pressure
LDL Cholesterol
Glycosylated Hemoglobin A
Risk Management
926 Citations

Liraglutide and cardiovascular outcomes in type 2 diabetes

Marso, S. P., Daniels, G. H., Frandsen, K. B., Kristensen, P., Mann, J. F. E., Nauck, M. A., Nissen, S. E., Pocock, S., Poulter, N. R., Ravn, L. S., Steinberg, W. M., Stockner, M., Zinman, B., Bergenstal, R. M., Buse, J. B. & LEADER Steering Committee on behalf of the LEADER Trial Investigators Jul 28 2016 In : New England Journal of Medicine. 375, 4, p. 311-322 12 p.

Research output: Contribution to journalArticle

Type 2 Diabetes Mellitus
Placebos
Confidence Intervals
Cause of Death
Stroke
1 Citations

Maria gordon buse, MD: A family affair through six decades of diabetes discovery

Burant, C. F., Buse, C. R., Robinson, K. A. & Buse, J. B. Jun 1 2016 In : Diabetes Care. 39, 6, p. 852-856 5 p.

Research output: Contribution to journalArticle

1 Citations

Microneedle-array patches loaded with hypoxia-sensitive vesicles provide fast glucose-responsive insulin delivery

Yu, J., Zhang, Y., Ye, Y., DiSanto, R., Sun, W., Ranson, D., Ligler, F. S., Buse, J. B. & Gu, Z. Feb 1 2016 In : Diabetes Technology and Therapeutics. 18, p. S54-S55

Research output: Contribution to journalComment/debate

Insulin
Glucose
Hypoxia
25 Citations

Microneedles Integrated with Pancreatic Cells and Synthetic Glucose-Signal Amplifiers for Smart Insulin Delivery

Ye, Y., Yu, J., Wang, C., Nguyen, N. Y., Walker, G. M., Buse, J. B. & Gu, Z. Apr 27 2016 In : Advanced Materials. 28, 16, p. 3115-3121 7 p.

Research output: Contribution to journalArticle

Insulin
Sugars
Glucose
Blood Glucose
Blood

More realistic power estimation for new user, active comparator studies: An empirical example

Gokhale, M., Buse, J. B., Pate, V., Marquis, M. A. & Stürmer, T. Apr 1 2016 In : Pharmacoepidemiology and Drug Safety. 25, 4, p. 462-466 5 p.

Research output: Contribution to journalArticle

Dipeptidyl-Peptidase IV Inhibitors
Prescriptions
Thiazolidinediones
Prescription Drugs
Medicare
34 Citations

Nine-year effects of 3.7 years of intensive glycemic control on cardiovascular outcomes

Gerstein, H. C. , Beavers, D. P. , Bertoni, A. G. , Bigger, J. T. , Buse, J. B. , Craven, T. E. , Cushman, W. C. , Fonseca, V. , Geller, N. L. , Giddings, S. J. , Grimm, R. H. , Genuth, S. , Hramiak, I. , Ismail-Beigi, F. , Jimenez, C. R. L. , Kirby, R. , Probstfield, J. , Riddle, M. C. , Seaquist, E. R. , Friedewald, W. T. & 1 others ACCORD Study Group May 1 2016 In : Diabetes Care. 39, 5, p. 701-708 8 p.

Research output: Contribution to journalArticle

Myocardial Infarction
Type 2 Diabetes Mellitus
Cause of Death
Mortality
Random Allocation
2 Citations

Novel measures of inflammation and insulin resistance are related to obesity and fitness in a diverse sample of 11-14 year olds: The HEALTHY Study

Jago, R., Drews, K. L., Otvos, J. D., Willi, S. M. & Buse, J. B. Jul 1 2016 In : International Journal of Obesity. 40, 7, p. 1157-1163 7 p.

Research output: Contribution to journalArticle

Insulin Resistance
Body Mass Index
Obesity
Lipoproteins
Inflammation
19 Citations

Once-daily delayed-release metformin lowers plasma glucose and enhances fasting and postprandial GLP-1 and PYY: results from two randomised trials

DeFronzo, R. A., Buse, J. B., Kim, T., Burns, C., Skare, S., Baron, A. & Fineman, M. Aug 1 2016 In : Diabetologia. 59, 8, p. 1645-1654 10 p.

Research output: Contribution to journalArticle

Glucagon-Like Peptide 1
Metformin
Fasting
Glucose
Hormones
28 Citations

Randomized Clinical Trial Comparing Basal Insulin Peglispro and Insulin Glargine in Patients with Type 2 Diabetes Previously Treated with Basal Insulin: IMAGINE 5

Buse, J. B., Rodbard, H. W., Serrano, C. T., Luo, J., Ivanyi, T., Bue-Valleskey, J., Hartman, M. L., Carey, M. A., Chang, A. M. & for the IMAGINE 5 Investigators Jan 1 2016 In : Diabetes Care. 39, 1, p. 92-100 9 p.

Research output: Contribution to journalArticle

Type 2 Diabetes Mellitus
Randomized Controlled Trials
Insulin
Hemoglobins
Hypoglycemia
34 Citations

Rationale and design of the EXenatide Study of Cardiovascular Event Lowering (EXSCEL) trial

Holman, R. R. , Bethel, M. A. , George, J. , Sourij, H. , Doran, Z. , Keenan, J. , Khurmi, N. S. , Mentz, R. J. , Oulhaj, A. , Buse, J. B. , Chan, J. C. , Iqbal, N. , Kundu, S. , Maggioni, A. P. , Marso, S. P. , Öhman, P. , Pencina, M. J. , Poulter, N. , Porter, L. E. , Ramachandran, A. & 2 others Zinman, B. & Hernandez, A. F. Apr 1 2016 In : American heart journal. 174, p. 103-110 8 p.

Research output: Contribution to journalArticle

Type 2 Diabetes Mellitus
exenatide
Placebos
Safety
Subcutaneous Injections
20 Citations

Risk factors associated with severe hypoglycemia in older adults with type 1 diabetes

Weinstock, R. S. , DuBose, S. N. , Bergenstal, R. M. , Chaytor, N. S. , Peterson, C. , Olson, B. A. , Munshi, M. N. , Perrin, A. J. S. , Miller, K. M. , Beck, R. W. , Liljenquist, D. R. , Aleppo, G. , Buse, J. B. , Kruger, D. , Bhargava, A. , Goland, R. S. , Edelen, R. C. , Pratley, R. E. , Peters, A. L. , Rodriguez, H. & 6 others Ahmann, A. J., Lock, J. P., Garg, S. K., Rickels, M. R., Hirsch, I. B. & T1D Exchange Severe Hypoglycemia in Older Adults With Type 1 Diabetes Study Group Apr 1 2016 In : Diabetes Care. 39, 4, p. 603-610 8 p.

Research output: Contribution to journalArticle

Type 1 Diabetes Mellitus
Hypoglycemia
Glucose
Glycosylated Hemoglobin A
C-Peptide
5 Citations

The author replies: Liraglutide and cardiovascular outcomes in type 2 diabetes

Buse, J. B. Nov 3 2016 In : New England Journal of Medicine. 375, 18, p. 1798-1799 2 p.

Research output: Contribution to journalLetter

Type 2 Diabetes Mellitus
Liraglutide
80 Citations

The primary glucose-lowering effect of metformin resides in the gut, not the circulation: Results from short-term pharmacokinetic and 12-week dose-ranging studies

Buse, J. B., DeFronzo, R. A., Rosenstock, J., Kim, T., Burns, C., Skare, S., Baron, A. & Fineman, M. Feb 1 2016 In : Diabetes Care. 39, 2, p. 198-205 8 p.

Research output: Contribution to journalArticle

Metformin
Pharmacokinetics
Glucose
Placebos
Biological Availability
19 Citations

Update and next steps for real-world translation of interventions for type 2 diabetes prevention: Reflections from a diabetes care editors' expert forum

Cefalu, W. T., Buse, J. B., Tuomilehto, J., Alexander Fleming, G., Ferrannini, E., Gerstein, H. C., Bennett, P. H., Ramachandran, A., Raz, I., Rosenstock, J. & Kahn, S. E. Jul 1 2016 In : Diabetes care. 39, 7, p. 1186-1201 16 p.

Research output: Contribution to journalReview article

Glucose Intolerance
Type 2 Diabetes Mellitus
Pharmacology
Prediabetic State
Metformin
2015
12 Citations

Cardiovascular safety of the glucagon-like peptide-1 receptor agonist taspoglutide in people with type 2 diabetes: An individual participant data meta-analysis of randomized controlled trials

Seshasai, S. R. K., Bennett, R. L., Petrie, J. R., Bengus, M., Ekman, S., Dixon, M., Herz, M., Buse, J. B. & Ray, K. K. May 1 2015 In : Diabetes, Obesity and Metabolism. 17, 5, p. 505-510 6 p.

Research output: Contribution to journalArticle

Type 2 Diabetes Mellitus
Meta-Analysis
Randomized Controlled Trials
Safety
Cardiovascular Diseases

Contribution of liraglutide in the fixed-ratio combination of insulin degludec and liraglutide (IDegLira)

Buse, J. B., Vilsbøll, T., Thurman, J., Blevins, T. C., Langbakke, I. H., Bøttcher, S. G. & Rodbard, H. W. Feb 1 2015 In : Diabetes Technology and Therapeutics. 17, p. S128-S129

Research output: Contribution to journalComment/debate

insulin degludec
Liraglutide
822 Citations

Effect of sitagliptin on cardiovascular outcomes in type 2 diabetes

Green, J. B., Bethel, M. A., Armstrong, P. W., Buse, J. B., Engel, S. S., Garg, J., Josse, R., Kaufman, K. D., Koglin, J., Korn, S., Lachin, J. M., McGuire, D. K., Pencina, M. J., Standl, E., Stein, P. P., Suryawanshi, S., Van De Werf, F., Peterson, E. D. & Holman, R. R. Jul 16 2015 In : New England Journal of Medicine. 373, 3, p. 232-242 11 p.

Research output: Contribution to journalArticle

Type 2 Diabetes Mellitus
Placebos
Hospitalization
Confidence Intervals
Cardiovascular Diseases
4 Citations

Efficacy, safety and tolerability of aleglitazar in patients with type 2 diabetes: Pooled findings from three randomized phase III trials

Henry, R. R., Buse, J. B., Wu, H., Durrwell, L., Mingrino, R., Jaekel, K., El Azzouzi, B., Andjelkovic, M. & Herz, M. Jun 1 2015 In : Diabetes, Obesity and Metabolism. 17, 6, p. 560-565 6 p.

Research output: Contribution to journalArticle

Type 2 Diabetes Mellitus
Safety
Metformin
Placebos
Insulin Resistance
218 Citations

Euglycemic diabetic ketoacidosis: A potential complication of treatment with sodium-glucose cotransporter 2 inhibition

Peters, A. L., Buschur, E. O., Buse, J. B., Cohan, P., Diner, J. C. & Hirsch, I. B. Sep 1 2015 In : Diabetes Care. 38, 9, p. 1687-1693 7 p.

Research output: Contribution to journalArticle

Sodium-Glucose Transport Proteins
Diabetic Ketoacidosis
Type 1 Diabetes Mellitus
Type 2 Diabetes Mellitus
Hope

Evaluation des effets cardiovasculaires du liraglutide: conception et donnees de base de l'etude Liraglutide effect and action in diabetes: Evaluation of cardiovascular outcome results (LEADER®)

Marre, M., Marso, S. P., Poulter, N. R., Nissen, S. E., Nauck, M. A., Zinman, B., Daniels, G. H., Pocock, S., Steinberg, W. M., Bergenstal, R. M., Mann, J. F. E., Steen Ravn, L., Brown Frandsen, K., Moses, A. C. & Buse, J. B. Jan 1 2015 In : Medecine des Maladies Metaboliques. 9, 3, p. 316-328 13 p.

Research output: Contribution to journalArticle

Random Allocation
Type 2 Diabetes Mellitus
Stroke
Myocardial Infarction
Placebos
16 Citations

Insulin dose and cardiovascular mortality in the ACCORD trial

Siraj, E. S., Rubin, D. J., Riddle, M. C., Miller, M. E., Hsu, F. C., Ismail-Beigi, F., Chen, S. H., Ambrosius, W. T., Thomas, A., Bestermann, W., Buse, J. B., Genuth, S., Joyce, C., Kovacs, C. S., O'connor, P. J., Sigal, R. J. & Solomon, S. Nov 1 2015 In : Diabetes Care. 38, 11, p. 2000-2008 9 p.

Research output: Contribution to journalArticle

Insulin
Mortality
Hypoglycemia
Meals
Therapeutics
14 Citations

Is insulin the most effective injectable antihyperglycaemic therapy?

Buse, J. B., Peters, A., Russell-Jones, D., Furber, S., Donsmark, M., Han, J., Macconell, L., Maggs, D. & Diamant, M. Feb 1 2015 In : Diabetes, Obesity and Metabolism. 17, 2, p. 145-151 7 p.

Research output: Contribution to journalArticle

Hypoglycemic Agents
Insulin
Injections
Weights and Measures
Glucose
7 Citations

LEADER 2: Baseline calcitonin in 9340 people with type 2 diabetes enrolled in the Liraglutide Effect and Action in Diabetes: Evaluation of cardiovascular outcome Results (LEADER) trial: Preliminary observations

Daniels, G. H., Hegedüs, L., Marso, S. P., Nauck, M. A., Zinman, B., Bergenstal, R. M., Mann, J. F. E., Derving Karsbøl, J., Moses, A. C., Buse, J. B., Tuttle, R. M. & on behalf of the LEADER trial investigators Jan 1 2015 In : Diabetes, Obesity and Metabolism. 17, 5, p. 477-486 10 p.

Research output: Contribution to journalArticle

Calcitonin
Type 2 Diabetes Mellitus
Serum
Glomerular Filtration Rate
Liraglutide
293 Citations

Management of hyperglycaemia in type 2 diabetes, 2015: a patient-centred approach. Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes

Inzucchi, S. E., Bergenstal, R. M., Buse, J. B., Diamant, M., Ferrannini, E., Nauck, M., Peters, A. L., Tsapas, A., Wender, R. & Matthews, D. R. Feb 6 2015 In : Diabetologia. 58, 3, p. 429-442 14 p.

Research output: Contribution to journalEditorial

Medical Societies
Disease Management
Hypoglycemic Agents
Hyperglycemia
Type 2 Diabetes Mellitus
1186 Citations

Management of Hyperglycemia in Type 2 Diabetes, 2015: A Patient-Centered Approach: Update to a position statement of the american diabetes association and the european association for the study of diabetes

Inzucchi, S. E., Bergenstal, R. M., Buse, J. B., Diamant, M., Ferrannini, E., Nauck, M., Peters, A. L., Tsapas, A., Wender, R. & Matthews, D. R. Jan 1 2015 In : Diabetes Care. 38, 1, p. 140-149 10 p.

Research output: Contribution to journalArticle

6 Citations

Medications for type 2 diabetes: how will we be treating patients in 50 years?

Kahn, S. E. & Buse, J. B. Aug 23 2015 In : Diabetologia. 58, 8, p. 1735-1739 5 p.

Research output: Contribution to journalEditorial

Type 2 Diabetes Mellitus
Anniversaries and Special Events
Hyperglycemia
Therapeutics
Public Health
16 Citations

Metabolomic characteristics of arsenic-associated diabetes in a prospective cohort in Chihuahua, Mexico

Martin, E. , González-Horta, C. , Rager, J. , Bailey, K. A. , Sánchez-Ramírez, B. , Ballinas-Casarrubias, L. , Ishida, M. C. , Gutiérrez-Torres, D. S. , Cerón, R. H. , Morales, D. V. , Terrazas, F. A. B. , Jesse Saunders, R. , Drobná, Z. , Mendez, M. A. , Buse, J. B. , Loomisk, D. , Jiakj, W. , García-Vargaskk, G. G. , Del Razo, L. M. , Stýblo, M. & 1 others Fry, R. Jan 1 2015 In : Toxicological Sciences. 144, 2, p. 338-346 9 p.

Research output: Contribution to journalArticle

Metabolomics
Arsenic
Medical problems
Mexico
Metabolites
114 Citations

Microneedle-array patches loaded with hypoxia-sensitive vesicles provide fast glucose-responsive insulin delivery

Yu, J., Zhang, Y., Ye, Y., DiSanto, R., Sun, W., Ranson, D., Ligler, F. S., Buse, J. B., Gu, Z. & Ho, D. Jul 7 2015 In : Proceedings of the National Academy of Sciences of the United States of America. 112, 27, p. 8260-8265 6 p.

Research output: Contribution to journalArticle

Insulin
Glucose
Hyaluronic Acid
Equipment and Supplies
Glucose Oxidase
48 Citations

One-year efficacy and safety of a fixed combination of insulin degludec and liraglutide in patients with type 2 diabetes: Results of a 26-week extension to a 26-week main trial

Gough, S. C. L., Bode, B. W., Woo, V. C., Rodbard, H. W., Linjawi, S., Zacho, M., Reiter, P. D. & Buse, J. B. Oct 1 2015 In : Diabetes, Obesity and Metabolism. 17, 10, p. 965-973 9 p.

Research output: Contribution to journalArticle

Type 2 Diabetes Mellitus
Safety
insulin degludec
Liraglutide
pioglitazone
20 Citations

Regional, age and sex differences in baseline characteristics of patients enrolled in the Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS)

Bethel, M. A., Green, J. B., Milton, J., Tajar, A., Engel, S. S., Califf, R. M., Holman, R. R., Armstrong, P. W., Buse, J. B., Josse, R. G., Kaufman, K., Koglin, J., Korn, S., Lachin, J. M., McGuire, D. K., Standl, E., Stein, P., Suryawanshi, S., Van de Werf, F. & TECOS Executive Committee Apr 1 2015 In : Diabetes, Obesity and Metabolism. 17, 4, p. 395-402 8 p.

Research output: Contribution to journalArticle

North America
Sex Characteristics
Eastern Europe
Latin America
Risk Management
64 Citations

Sotagliflozin, a dual SGLT1 and SGLT2 inhibitor, as adjunct therapy to insulin in type 1 diabetes

Sands, A. T., Zambrowicz, B. P., Rosenstock, J., Lapuerta, P., Bode, B. W., Garg, S. K., Buse, J. B., Banks, P., Heptulla, R., Rendell, M., Cefalu, W. T. & Strumph, P. Jul 1 2015 In : Diabetes Care. 38, 7, p. 1181-1188 8 p.

Research output: Contribution to journalArticle

Type 1 Diabetes Mellitus
Insulin
Placebos
Glucose
Therapeutics

Subcutaneous injection of hyaluronidase with recombinant human insulin compared with insulin lispro in type 1 diabetes

Garg, S. K., Buse, J. B., Skyler, J. S., Vaughn, D. E. & Muchmore, D. B. Feb 1 2015 In : Diabetes Technology and Therapeutics. 17, p. S45-S46

Research output: Contribution to journalComment/debate

Insulin Lispro
Hyaluronoglucosaminidase
Subcutaneous Injections
Type 1 Diabetes Mellitus
Insulin